The image shows one form of CINDU, cold urticaria, in a patient who had been swimming in cold water. Novartis is on course to expand the label for its recently approved oral BTK inhibitor Rhapsido, ...
Roche's oral BTK inhibitor fenebrutinib has hit the spot in the final trial in its phase 3 programme, in relapsing multiple sclerosis (RMS), and is now being prepared for regulatory filings. The ...
"I think he thought I was his secretary," forensic psychologist Dr. Katherine Ramsland told attendees at CrimeCon 2022 about her years interviewing and analyzing BTK Killer Dennis Rader. "I thought, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results